Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 47, Issue 4, 2014, Pages 324-332

  Chuang, Yu Chung ^a   Sheng, Wang Huei ^a   Lauderdale, Tsai Ling ^b   Li, Shu Yin ^c   Wang, Jann Tay ^a   Chen, Yee Chun ^a,d   Chang, Shan Chwen ^a,d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CENTER FOR DISEASE CONTROL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Acinetobacter; Epidemiology; Genospecies

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBAPENEM; CARBAPENEMASE; CIPROFLOXACIN; COLISTIN; IMIPENEM; RNA 16S; RNA 23S; SULTAMICILLIN; TIGECYCLINE; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER NOSOCOMIALIS; ACINETOBACTER PITTII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN; ACINETOBACTER INFECTIONS; CLUSTER ANALYSIS; DRUG EFFECTS; GENETICS; GENOTYPE; HEALTH SURVEY; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PUBLIC HEALTH SURVEILLANCE; TAIWAN;

EID: 84904498158     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2013.03.008     Document Type: Article

References (27)

1. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
2. Fishbain J., Peleg A.Y. Treatment of Acinetobacter infections. Clin Infect Dis 2010, 51:79-84.
3. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006, 12:826-836.
4. Gerner-Smidt P., Tjernberg I., Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol 1991, 29:277-282.
5. Gerner-Smidt P. Ribotyping of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. J Clin Microbiol 1992, 30:2680-2685.
6. Chuang Y.C., Sheng W.H., Li S.Y., Lin Y.C., Wang J.T., Chen Y.C., et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia. Clin Infect Dis 2011, 52:352-360.
7. Lauderdale T.L., Clifford McDonald L., Shiau Y.R., Chen P.C., Wang H.Y., Lai J.F., et al. The status of antimicrobial resistance in Taiwan among Gram-negative pathogens: the Taiwan surveillance of antimicrobial resistance (TSAR) program. Diagn Microbiol Infect Dis 2000, 2004(48):211-219.
8. Seifert H., Dolzani L., Bressan R., van der Reijden T., van Strijen B., Stefanik D., et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005, 43:4328-4335.
9. Nemec A., Krizová L., Maixnerová M., Diancourt L., van der Reijden T.J., Brisse S., et al. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother 2008, 62:484-489.
10. Schreckenberger P.C., von Graevenitz A. Acinetobacter, Achromobacter, Acaligenes, Moraxella, Methylobacterium, and other nonfermentative Gram-negative rods. Manual of clinical microbiology 2000, 539-560. ASM Press, Washington DC. 7th ed. P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken (Eds.).
11. Lin Y.C., Sheng W.H., Chang S.C., Wang J.T., Chen Y.C., Wu R.J., et al. Application of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities. J Clin Microbiol 2008, 46:612-617.
12. Performance standards for antimicrobial susceptibility testing 2007, Clinical and Laboratory Standards Institute, 17th informational supplement, CLSI, Wayne, PA, p. 40-41.
13. Jones R.N., Ferraro M.J., Reller L.B., Schreckenberger P.C., Swenson J.M., Sader H.S. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 2007, 45:227-230.
14. Pitout J.D., Gregson D.B., Poirel L., McClure J.A., Le P., Church D.L. Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory. J Clin Microbiol 2005, 43:3129-3135.
15. Woodford N., Ellington M.J., Coelho J.M., Turton J.F., Ward M.E., Brown S., et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006, 27:351-353.
16. Lin Y.C., Hsia K.C., Chen Y.C., Sheng W.H., Chang S.C., Liao M.H., et al. Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan. Antimicrob Agents Chemother 2010, 54:2078-2084.
17. Zarrilli R., Crispino M., Bagattini M., Barretta E., Di Popolo A., Triassi M., et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol 2004, 42:946-953.
18. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
19. EUCAST technical note on tigecycline. Clin Microbiol Infect 2006, 12:1147-1149. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee.
20. Diancourt L., Passet V., Nemec A., Dijkshoorn L., Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 2010, 5:e10034.
21. Yang S.C., Chang W.J., Chang Y.H., Tsai Y.S., Yang T.P., Juan C.W., et al. Prevalence of antibiotics resistance and OXA carbapenemases genes in multidrug-resistant Acinetobacter baumannii isolates in central Taiwan. Eur J Clin Microbiol Infect Dis 2010, 29:601-604.
22. Chen C.M., Liu P.Y., Ke S.C., Wu H.J., Wu L.T. Investigation of carbapenem-resistant Acinetobacter baumannii isolates in a district hospital in Taiwan. Diagn Microbiol Infect Dis 2009, 63:394-397.
23. Lu P.L., Doumith M., Livermore D.M., Chen T.P., Woodford N. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. J Antimicrob Chemother 2009, 63:641-647.
24. Lee Y.T., Huang L.Y., Chiang D.H., Chen C.P., Chen T.L., Wang F.D., et al. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan. Int J Antimicrob Agents 2009, 34:580-584.
25. Merkier A.K., Catalano M., Ramírez M.S., Quiroga C., Orman B., Ratier L., et al. Polyclonal spread of bla(OXA-23) and bla(OXA-58) in Acinetobacter baumannii isolates from Argentina. J Infect Dev Ctries 2008, 2:235-240.
26. Lin Y.C., Sheng W.H., Chen Y.C., Chang S.C., Hsia K.C., Li S.Y. Differences in carbapenem resistance genes among Acinetobacter baumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan. Int J Antimicrob Agents 2010, 35:439-443.
27. Sheng W.H., Lin Y.C., Wang J.T., Chen Y.C., Chang S.C., Hsia K.C., et al. Identification of distinct ciprofloxacin susceptibility in Acinetobacter spp. by detection of the gyrA gene mutation using real-time PCR. Mol Cell Probes 2009, 23:154-156.